OS Therapies
PublicOS Therapies is now publicly traded
The data on this page reflects OS Therapies's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Private Placement
Oct 15, 2026
Total Funding Raised
$24.71M
Company Overview
OS Therapies has raised $24.71M. It was founded in 2018.
OS Therapies is a clinical-stage biopharmaceutical company that focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors.
AI Layer
Non-AI
OS Therapies Comparables
Compare OS Therapies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlaMab Therapeutics, Inc. | 77% |
For institutional investors. Book with your work email.
OS Therapies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Oct 15, 2026 | ||||
| Convertible Debt | Jun 30, 2026 | ||||
| Seed Round | Mar 4, 2026 | ||||
| Private Placement | Sep 2, 2025 | ||||
| Private Placement | Dec 31, 2024 | ||||
Private Placement | Dec 8, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
OS Therapies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.